ask="4.10"
ask_size="2600"
average_daily_volume="123157"
bid="N/A"
bid_size="N/A"
book_value="2.84"
change="+0.05"
change_from_200_day_moving_average="0.03"
change_from_50_day_moving_average="1.03"
change_from_52_week_high="-2.59"
change_From_52_week_low="1.80"
change_in_percent="+1.33%"
close="3.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.04"
ebitda="-37.85M"
eps_estimate_current_year="-1.83"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="5860000"
high="4.05"
high_52_weeks="6.39"
last_trade_date="3/10/2017"
last_trade_price="3.80"
last_trade_size="241"
last_trade_time="4:00pm"
low="3.70"
low_52_weeks="2.00"
market_capitalization="80.58M"
moving_average_200_day="3.77"
moving_average_50_day="2.77"
name="Strongbridge Biopharma plc - Or"
notes="N/A"
one_year_target_price="18.00"
open="3.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.81%"
percent_change_from_50_day_moving_average="+37.25%"
percent_change_from_52_week_high="-40.53%"
percent_change_from_52_week_low="+90.00%"
previous_close="3.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.32"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21205000"
short_ratio="0.56"
stock_exchange="NMS"
symbol="SBBP"
volume="14639"
weeks_range_52="2.00 - 6.39"
